Orthofix Medical (OFIX) Cash from Financing Activities (2010 - 2026)

Orthofix Medical has disclosed Cash from Financing Activities across 17 years of filings, most recently posting $64.0 million for Q1 2026.

• Quarterly Cash from Financing Activities rose 9926.42% year-over-year to $64.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.8 million (up 123.16% YoY) and the FY2025 annual result came in at -$786000.0, down 101.55% from the prior year.
• Cash from Financing Activities grew to $64.0 million in Q1 2026, from $2.4 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $64.0 million in Q1 2026 and troughed at -$5.2 million in Q3 2025.
• A 5-year average of $10.5 million and a median of $2.4 million in 2025 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 301.17% — and 2026, when it jumped 9926.42%.
• Tracing OFIX's Cash from Financing Activities over 5 years: stood at $1.5 million in 2022, then soared by 1587.58% to $25.3 million in 2023, then increased by 24.55% to $31.5 million in 2024, then slumped by 92.45% to $2.4 million in 2025, then soared by 2591.21% to $64.0 million in 2026.
• Business Quant data shows OFIX's Cash from Financing Activities at $64.0 million in Q1 2026, $2.4 million in Q4 2025, and -$5.2 million in Q3 2025.